In the most recent quarter (Q3), Eloxx Pharmaceuticals reported EPS of $-1.31, beating estimates of $-1.97 by 0.34%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Eloxx Pharmaceuticals has averaged an EPS surprise of 0.19% and a revenue surprise of 1.00%.
Analyze the earnings history of Eloxx Pharmaceuticals using advanced sorting and filters.
The chart below shows Eloxx Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2023-11-13 | $-1.31 | $-1.97 | 33.5 % |
| Q2 | 2023-08-14 | $-1.96 | $-1.54 | -27.3 % |
| Q1 | 2023-05-15 | $-2.88 | $-2.55 | -12.9 % |
| Q4 | 2023-04-03 | $-2.92 | $-2.97 | 1.68 % |
The chart below shows Eloxx Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2023-05-15 | $0 | $700.00K | -100.0 % |
| Q2 | 2022-08-15 | $0 | $2.33M | -100.0 % |
| Q1 | 2022-05-10 | $0 | $3.50M | -100.0 % |
Eloxx Pharmaceuticals (ELOX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2023 for Q3.
Eloxx Pharmaceuticals (ELOX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2023 for Q3 and the Actual EPS was $-1.31, which beat the estimate of $-1.97.
Eloxx Pharmaceuticals (ELOX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2023 for Q3 and the Actual Revenue was $0.00, which hit the estimate of $0.00.